OMGA insider filings

Omega Therapeutics, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2024-12-05. Screen OMGA transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for OMGA between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — Omega Therapeutics, Inc.

FiledFormInsiderReported transactionsSource
2024-12-054Mehrotra Ravi — DirectorGrant/award (A): 50,000 (derivative) @ $0EDGAR
2024-11-264Nelson Jennifer Ann — Chief Scientific OfficerGrant/award (A): 110,000 (derivative) @ $0EDGAR
2024-11-154Certel Kaan — See Remarks, DirectorGrant/award (A): 340,000 (derivative) @ $0EDGAR
2024-10-044Rosiello Robert L. — DirectorGrant/award (A): 50,000 (derivative) @ $0EDGAR
2024-06-214Levy Elliott M. — DirectorGrant/award (A): 25,000 (derivative) @ $0EDGAR
2024-06-214Werner Michelle C — DirectorGrant/award (A): 25,000 (derivative) @ $0EDGAR
2024-06-214Boehm Rainer J. — DirectorGrant/award (A): 25,000 (derivative) @ $0EDGAR
2024-06-214Young Richard A — DirectorGrant/award (A): 25,000 (derivative) @ $0EDGAR
2024-06-214Szela Mary T — DirectorGrant/award (A): 25,000 (derivative) @ $0EDGAR
2024-06-214Kender Richard N — DirectorGrant/award (A): 50,000 (derivative) @ $0EDGAR
2024-06-214MENDLEIN JOHN — DirectorGrant/award (A): 25,000 (derivative) @ $0EDGAR
2024-06-214SCHADE CHRISTIAN S — DirectorGrant/award (A): 25,000 (derivative) @ $0EDGAR
2024-05-314Certel Kaan — Chief Business OfficerGrant/award (A): 220,000 (derivative) @ $0EDGAR
2024-02-094McCauley Thomas — Chief Scientific OfficerGrant/award (A): 125,000 (derivative) @ $0 · Grant/award (A): 75,000 (derivative) @ $0EDGAR
2024-02-094Karande Mahesh — President and CEO, DirectorGrant/award (A): 209,551 (derivative) @ $0 · Grant/award (A): 314,326 (derivative) @ $0EDGAR
2024-02-094Moore Yan — Chief Medical OfficerGrant/award (A): 110,000 (derivative) @ $0EDGAR
2024-02-094Zeng Ling — See RemarksGrant/award (A): 125,000 (derivative) @ $0EDGAR
2024-02-094Reed Joshua — Chief Financial OfficerGrant/award (A): 110,000 (derivative) @ $0EDGAR
2024-02-094SCHADE CHRISTIAN S — DirectorGrant/award (A): 512,848 (derivative) @ $0EDGAR
2024-02-094/ASCHADE CHRISTIAN S — DirectorGrant/award (A): 36,713 (derivative) @ $0EDGAR
2023-08-294Werner Michelle C — DirectorGrant/award (A): 36,713 (derivative) @ $0EDGAR
2023-07-124SCHADE CHRISTIAN S — DirectorGrant/award (A): 36,713 (derivative) @ $0EDGAR
2023-06-094Levy Elliott M. — DirectorGrant/award (A): 18,118 (derivative) @ $0EDGAR
2023-06-094Boehm Rainer J. — DirectorGrant/award (A): 18,118 (derivative) @ $0EDGAR
2023-06-094Young Richard A — DirectorGrant/award (A): 18,118 (derivative) @ $0EDGAR
2023-06-094Szela Mary T — DirectorGrant/award (A): 18,118 (derivative) @ $0EDGAR
2023-06-094MENDLEIN JOHN — DirectorGrant/award (A): 18,118 (derivative) @ $0EDGAR
2023-06-094AFEYAN NOUBAR — Director, 10% ownerGrant/award (A): 18,118 (derivative) @ $0EDGAR
2023-06-094BESHAR LUKE M — DirectorGrant/award (A): 18,118 (derivative) @ $0EDGAR
2023-06-054Young Richard A — DirectorSale (S): 5,000 @ $8EDGAR
2023-05-034Young Richard A — DirectorSale (S): 5,000 @ $8EDGAR
2023-04-104Young Richard A — DirectorSale (S): 5,000 @ $8EDGAR
2023-03-204Young Richard A — DirectorSale (S): 10,000 @ $8EDGAR
2023-03-024McManus Kevin — Chief Human Resources OfficerGrant/award (A): 55,000 (derivative) @ $0EDGAR
2023-03-024Moore Yan — Chief Medical OfficerGrant/award (A): 55,000 (derivative) @ $0EDGAR
2023-03-024Karande Mahesh — President and CEO, DirectorGrant/award (A): 170,000 (derivative) @ $0EDGAR
2023-03-024McCauley Thomas — Chief Scientific OfficerGrant/award (A): 55,000 (derivative) @ $0EDGAR
2023-03-024Zeng Ling — See RemarksGrant/award (A): 55,000 (derivative) @ $0EDGAR
2023-03-024Reed Joshua — Chief Financial OfficerGrant/award (A): 55,000 (derivative) @ $0EDGAR
2023-02-274Flagship Pioneering Inc. — 10% owner
Flagship Pioneering Special Opportunities Fund II General Partner LLC — 10% owner
Flagship Pioneering Special Opportunities Fund II, L.P. — 10% owner
AFEYAN NOUBAR — Director, 10% owner
Purchase (P): 1,993,986 @ $5.78 · Purchase (P): 1,329,324 @ $5.78EDGAR
2023-01-114Young Richard A — DirectorSale (S): 20,000 @ $8EDGAR
2022-10-284Karande Mahesh — President and CEO, DirectorGrant/award (A): 170,000 (derivative) @ $0EDGAR
2022-10-284McCauley Thomas — Chief Scientific OfficerGrant/award (A): 55,000 (derivative) @ $0EDGAR
2022-10-284McManus Kevin — Chief Human Resources OfficerGrant/award (A): 55,000 (derivative) @ $0EDGAR
2022-10-284Moore Yan — Chief Medical OfficerGrant/award (A): 55,000 (derivative) @ $0EDGAR
2022-10-284Zeng Ling — See RemarksGrant/award (A): 55,000 (derivative) @ $0EDGAR
2022-10-284Reed Joshua — Chief Financial OfficerGrant/award (A): 55,000 (derivative) @ $0EDGAR
2022-09-154Young Richard A — DirectorSale (S): 10,000 @ $8EDGAR
2022-09-014Boehm Rainer J. — DirectorGrant/award (A): 36,713 (derivative) @ $0EDGAR
2022-06-104BESHAR LUKE M — DirectorGrant/award (A): 18,118 (derivative) @ $0EDGAR

Recent 8-K events — Omega Therapeutics, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2025-02-248-K1.01 — Entry into a Material Definitive Agreement
3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
EDGAR
2025-02-148-K1.01 — Entry into a Material Definitive Agreement
1.03 — Bankruptcy or Receivership
2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
EDGAR
2025-02-038-K1.01 — Entry into a Material Definitive Agreement
1.02 — Termination of a Material Definitive Agreement
2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
8.01 — Other Events
EDGAR
2025-01-288-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2025-01-178-K2.04 — Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet ArrangementEDGAR
2025-01-108-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2024-12-318-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
8.01 — Other Events
EDGAR
2024-12-068-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2024-11-148-K1.01 — Entry into a Material Definitive Agreement
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2024-10-048-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=OMGA returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs